Melanoma, a tumor arising from a melanocyte (the cell responsible for producing pigment),
continues to carry the potential to be a deadly disease. In the United States, 91,320 new …

During the coronavirus disease 2019 (COVID‐19) pandemic, providers and patients must
engage in shared decision making regarding the pros and cons of early versus delayed …

Malignant melanoma is considered to be one of the deadliest types of skin cancers which is
responsible for the massive number of deaths worldwide. According to the American Cancer …

Background As advancements in artificial intelligence (AI) continue, large language models
(LLMs) have emerged as promising tools for generating medical information. Their rapid …

Background and objective: Skin cancer is recognized as the most common kind of cancer in
the world. It could be deadly if not identified at the primary stage, which makes early …

Background Although most patients with cutaneous melanoma are non-Hispanic whites
(NHWs), minorities consistently suffer worse melanoma-specific survival (MSS). Much of the …

Due to the COVID-19 pandemic, planned medical and surgical activities are being
postponed. For the dermatology community, this interruption to the healthcare system can …

Background Longer time from diagnosis to definitive surgery (TTDS) is associated with
increased melanoma-specific mortality. Although black patients present with later-stage …

Importance Melanoma treatment has evolved during the past decade with the adoption of
adjuvant and palliative immunotherapy and targeted therapies, with an unclear impact on …

Background Changes in the management of patients with cancer and delays in treatment
delivery during the COVID-19 pandemic may impact the use of hospital resources and …